Related Experiment Video
Updated: Dec 24, 2025

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
Frontotemporal Dementia: Correlations Between Psychiatric Symptoms and Pathology
Marta Scarioni1,2,3,4, Priya Gami-Patel1, Yannick Timar2
1Department of Pathology, Amsterdam University Medical Centers, Location VUmc, Amsterdam Neuroscience, Amsterdam, The Netherlands.
Neuropsychiatric symptoms in frontotemporal dementia (FTLD) can indicate specific underlying pathologies like TAR DNA-binding protein-43 (TDP-43). Routine evaluation of these symptoms aids in diagnosing FTLD and guiding molecular trials.
Area of Science:
- Neuroscience
- Neuropathology
- Clinical Neurology
Background:
- Frontotemporal lobar degeneration (FTLD) presents with diverse pathologies, primarily aggregated TAR DNA-binding protein-43 (TDP-43), tau, or fused in sarcoma (FUS).
- Predicting FTLD pathology from clinical presentation remains challenging.
Purpose of the Study:
- To investigate the correlation between specific clinical symptoms, including neuropsychiatric features, and underlying FTLD pathology.
- To determine if clinical presentation can predict molecular subtypes of FTLD.
Main Methods:
- A cohort of 150 brain donors with frontotemporal dementia was analyzed.
- Clinical symptoms, including neuropsychiatric features like hallucinations and delusions, were scored and compared across pathological groups (TDP-43, tau, FUS, and non-FTLD).
Main Results:
- Hyperorality was a significant indicator of FTLD pathology versus non-FTLD pathology.
- Hallucinations in early disease stages were associated with TDP-43 pathology, including C9orf72 repeat expansion carriers.
- Perseverative or compulsive behaviors were more prevalent in specific TDP-43 histotypes (TDP-B and TDP-C).
Conclusions:
- Neuropsychiatric symptoms are prevalent in FTLD and serve as valuable indicators of specific underlying pathologies.
- Routine assessment of neuropsychiatric symptoms in frontotemporal dementia patients is recommended to improve diagnostic accuracy and patient stratification for clinical trials.
Related Concept Videos
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Negative and Cognitive Symptoms of Schizophrenia
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Dementia
The progression of dementia is generally gradual....
Positive Symptoms of Schizophrenia: Hallucinations and Delusions
Thought Disorders
Disorganized and unusual thought processes mark thought disorders in schizophrenia. One key feature is disorganized speech, where an individual's conversation includes...
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Positive Symptoms Schizophrenia: Hallucinations and Delusions
Hallucinations
Hallucinations in...

